Prosecution Insights
Last updated: April 19, 2026

Iambic Therapeutics Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19025976 METHODS OF USE FOR AZA-QUINAZOLINE COMPOUNDS FETTEROLF, BRANDON J 1626 Non-Final OA Jan 16, 2025
18453798 COMPOUNDS AND METHODS FOR MODULATING HER2 PATEL, SAGAR S 1626 Non-Final OA Aug 22, 2023
18357320 AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE FETTEROLF, BRANDON J 1626 Non-Final OA Jul 24, 2023
17332951 Systems and Methods for Determining Molecular Properties with Atomic-Orbital-Based Features PULLIAM, JOSEPH CONSTANTINE 1687 Non-Final OA May 27, 2021

Managing Iambic Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month